A claim you hear on longevity podcasts

Does metformin blunt blood sugar spikes after meals?

Strong consensus for. Of 10 studies that test it, 6 agree and 4 partly agree.

Best for:
People timing metformin around their meals
Price:
Free to read, with every receipt. Pro is $9 a month or $79 a year and adds AI Ask.

The claim checked: Metformin taken with a meal cuts the blood sugar spike after eating Hear it at 1:10:06

PrecisRECEIPT FOR A CLAIM


Does metformin blunt blood sugar spikes after meals?


  • 4 × TrialAGREE
  • 3 × TrialPARTLY
  • 2 × StudyAGREE
  • 1 × StudyPARTLY

TOTAL6 AGREE / 4 PARTLY

Strong consensus for

What do the studies say?

Strong consensus for

6 of 10 studies agree, and none disagree. In a trial in 16 adults with type 2 diabetes, metformin taken before or with a meal cut the rise in blood sugar after it. A trial in 20 women with type 2 diabetes found the same, whether the pill came before or after the meal. 4 studies partly agree: the drop was small, showed up at only some time points, or became clear only after exercise. Most of these studies were in people with type 2 diabetes. In healthy young men, a trial found metformin stopped a steroid from raising the after-meal spike.

Computed from 10 studies that test this point, each judged by two readers, in full. 10 more studies are waiting for a full read and do not count yet.

What was said on the podcast?

“All I'm just saying is that in humans that glucose spike can be reduced by metformin.”
Nav Chandel, a guest on The Drive · 416 ‒ The science of mitochondria: their role in health, aging, disease, and much more · 1:10:06 on YouTube
Episode check NAD boosters won't slow aging, the episode says. Of 10 studies, 2 agree, 1 disagrees and 7 partly agree. 6 claims checked against 59 studies · 22 chapters not checked yet See the whole episode →
The point checked Strong consensus for

Metformin taken with or before a meal reduces the rise in blood glucose after that meal

Agree 6

controlled trial · 2024

“Compared with the control, Met (−60 min), Met (−30 min) and Met (0 min) all reduced the plasma glucose iAUC 0–120min ( p <0.01 for each), but the magnitude of this reduction was greater after Met (−60 min) and Met (−30 min) compared with Met (0 min) ( p =0.03 and p =0.001, respectively).”

Impact of the timing of metformin administration on glycaemic and glucagon-like peptide-1 responses to intraduodenal glucose infusion in type 2 diabetes: a double-blind, randomised, placebo-controlled, crossover study. Diabetologia
Who: 16 adults with type 2 diabetes on stable metformin monotherapy (14 men, 2 women; age 69.9±1.9 years; BMI 28.7; HbA1c 6.6%)
PMID 38561463

controlled trial · 2026

“As shown in Figure 1A , both premeal or postmeal metformin administration significantly lowered PPG levels at 1, 2 and 3 h after standardized mixed‐meals compared with the condition without metformin.”

Effects of Premeal Versus Postmeal Metformin Administration on Postmeal Glycemic Control in Individuals With Type 2 Diabetes Mellitus: A Randomized, 8-Week Crossover Study. Diabetes Obes Metab
Who: 20 women with type 2 diabetes aged 18-65 (mean 48.9) on immediate-release metformin monotherapy, HbA1c 6.5-8.5% (mean 7.0%)
PMID 41994908

other primary study · 1990

“The metformin effect was most dramatic from noon on, with very little increase in plasma glucose concentration seen in metformin-treated patients after the midday meal.”

Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients. Diabetes Care
Who: 12 patients with NIDDM (7 men, 5 women; 56 ± 3 years; BMI 29.7) with fasting glucose >180 mg/dl after failed diet, on no other antidiabetic drug
PMID 2404714

other primary study · 1994

“It is apparent that day-long plasma glucose concentrations were significantly lower after metformin treatment (P < 0.001), particularly from 1200 to 1600.”

Effect of metformin on postprandial lipemia in patients with fairly to poorly controlled NIDDM. Diabetes Care
Who: 16 glipizide-treated patients with NIDDM (10 men, 6 women; 57 ± 3 years; BMI 28.0) with fasting glucose >8.3 mmol/l on maximal sulfonylurea
PMID 7821127

Show 2 more Show fewer

controlled trial · 2013

“Mean post-MTT plasma glucose decreased from 207 ± 5 mg/dL (P) to 191 ± 4 mg/dL (M), to 195 ± 4 mg/dL (S) (both P < 0.01 vs. P), and to 161 ± 3 mg/dL (M+S) ( P < 0.01 vs. M and S).”

Mechanisms of glucose lowering of dipeptidyl peptidase-4 inhibitor sitagliptin when used alone or with metformin in type 2 diabetes: a double-tracer study. Diabetes Care
Who: 16 patients with type 2 diabetes (9 men, 7 women; 47 ± 3 years; BMI 33.5; A1C 8.8%)
PMID 23579178

controlled trial · 2025

“Metformin enhanced whole-body insulin sensitivity, as assessed by the Matsuda index, by inhibiting the postprandial increase in glucose and insulin levels.”

Short-term Metformin Protects Against Glucocorticoid-Induced Toxicity in Healthy Individuals: A Randomized, Double-Blind, Placebo-Controlled Trial. Diabetes Care
Who: Healthy, lean men aged 18-40 years (mean 27.0 +/- 5.2), BMI 18.5-25 kg/m2, all given prednisone 30 mg/day to induce glucocorticoid excess; randomized, double-blind, placebo-controlled crossover at University Hospital Basel
PMID 39899467

Partly agree 4

other primary study · 2018

“Metformin therapy decreased 2‐hour glucose over placebo, insulin AUC, and insulin secretion using C‐peptide deconvolution and improved low‐density lipoprotein and triglycerides (Table 1 ).”

Metformin regulates metabolic and nonmetabolic pathways in skeletal muscle and subcutaneous adipose tissues of older adults. Aging Cell
Who: glucose-intolerant older adults (impaired glucose tolerance)
PMID 29383869

controlled trial · 2011

“As shown in Fig. 1 , the mean glucose concentration continued to be lower throughout the day in the metformin conditions compared with placebo, with the difference becoming statistically significant after exercise.”

Metformin and exercise in type 2 diabetes: examining treatment modality interactions. Diabetes Care
Who: 10 adults with type 2 diabetes (8 men, 2 postmenopausal women; 58 ± 6 years; A1C 6.5%) not taking glucose-lowering medication
PMID 21602430

controlled trial · 2018

“While the median absolute change from baseline was larger for all evaluated parameters except for PP2 in the high-dose group, none of the values were statistically different between the two groups ( Table 2 , S1 Fig ).”

A non-linear pharmacokinetic-pharmacodynamic relationship of metformin in healthy volunteers: An open-label, parallel group, randomized clinical study. PLoS One
Who: 20 healthy male volunteers aged 20-45 years without glucose intolerance
PMID 29342199

controlled trial · 2023

“The 2h-PBG and BG AUC were also lower in the Ins+SZ-A group than in the Ins+Met and Ins groups (P<0.05; Figure 2F ).”

Effects of mulberry twig alkaloids(Sangzhi alkaloids) and metformin on blood glucose fluctuations in combination with premixed insulin-treated patients with type 2 diabetes. Front Endocrinol (Lausanne)
Who: 30 hospitalized patients with type 2 diabetes aged 18-70, HbA1c 7-10% on oral agents, switched to premixed insulin
PMID 38027146

Disagree 0· none of the studies we read

More on supplements and drugs

The Precis Weekly

Get each new check by email.

One email a week with the claims and episodes we checked, what the studies found and the minute each claim was said.

Free. Unsubscribe anytime.